Atrium Therapeutics, Inc. Common Stock Net Asset Quality Index
Atrium Therapeutics, Inc. Common Stock net asset quality index. Atrium Therapeutics, Inc. Common Stock (RNA) has a Net Asset Quality Index of 74.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $278.35 Million minus total liabilities of $71.07 Million yields net assets of $207.29 Million. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Atrium Therapeutics, Inc. Common Stock for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Atrium Therapeutics, Inc. Common Stock (2011–2025)
Net asset quality index of Atrium Therapeutics, Inc. Common Stock from 2011 to 2025. This chart shows how Atrium Therapeutics, Inc. Common Stock's Net Asset Quality Index has evolved across 11 annual periods from 2011 to 2025. As of December 2025, the index stands at 74.5%, representing net assets of $207.29 Million against total assets of $278.35 Million USD. Check RNA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Atrium Therapeutics, Inc. Common Stock Net Asset Quality Index by Year (2011–2025)
Atrium Therapeutics, Inc. Common Stock net asset quality index by year from 2011 to 2025. The table below presents the year-by-year Net Asset Quality Index for Atrium Therapeutics, Inc. Common Stock from 2011 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see RNA market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.5% | $207.29 Million | $278.35 Million | $71.07 Million | ▼ -16.6 pp |
| 2024 | 91.1% | $1.42 Billion | $1.56 Billion | $138.94 Million | ▲ +11.4 pp |
| 2023 | 79.7% | $500.76 Million | $628.55 Million | $127.79 Million | ▼ -10.8 pp |
| 2022 | 90.5% | $578.08 Million | $638.80 Million | $60.73 Million | ▲ +1.3 pp |
| 2021 | 89.2% | $381.43 Million | $427.58 Million | $46.15 Million | ▼ -2.5 pp |
| 2020 | 91.7% | $306.22 Million | $333.90 Million | $27.68 Million | ▲ +159.2 pp |
| 2019 | -67.4% | $-65.36 Million | $96.91 Million | $162.26 Million | ▲ +965.4 pp |
| 2018 | -1032.9% | $-41.13 Million | $3.98 Million | $45.11 Million | ▼ -1102.5 pp |
| 2013 | 69.6% | $87.10 Million | $125.10 Million | $38.00 Million | ▲ +36.7 pp |
| 2012 | 32.9% | $20.54 Million | $62.41 Million | $41.87 Million | ▲ +22.5 pp |
| 2011 | 10.4% | $3.41 Million | $32.68 Million | $29.27 Million | — |